Cargando…

Production of SARS-CoV-2 Virus-Like Particles in Insect Cells

Coronavirus disease (COVID-19) causes a serious threat to human health. Virus-like particles (VLPs) constitute a promising platform in SARS-CoV-2 vaccine development. In this study, the E, M, and S genes were cloned into multiple cloning sites of a new triple expression plasmid with one p10 promoter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mi, Youjun, Xie, Tao, Zhu, Bingdong, Tan, Jiying, Li, Xuefeng, Luo, Yanping, Li, Fei, Niu, Hongxia, Han, Jiangyuan, Lv, Wei, Wang, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227081/ https://www.ncbi.nlm.nih.gov/pubmed/34073159 http://dx.doi.org/10.3390/vaccines9060554

Ejemplares similares

Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and “Non-BCG” Antigens to Induce Long-Term Immune Memory
por: Lv, Wei, et al.
Publicado: (2022)

Id3 and Bcl6 Promote the Development of Long-Term Immune Memory Induced by Tuberculosis Subunit Vaccine
por: Han, Jiangyuan, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity
por: Mi, Youjun, et al.
Publicado: (2022)

Fusion Cytokines IL-7-Linker-IL-15 Promote Mycobacterium Tuberculosis Subunit Vaccine to Induce Central Memory like T Cell-Mediated Immunity
por: Bai, Chunxiang, et al.
Publicado: (2020)

Severe persistent mycobacteria antigen stimulation causes lymphopenia through impairing hematopoiesis
por: Li, Fei, et al.
Publicado: (2023)

Identification of Novel Genes Involved in Escherichia coli Persistence to Tosufloxacin
por: Li, Tuodi, et al.
Publicado: (2020)

Baculovirus-Free SARS-CoV-2 Virus-like Particle Production in Insect Cells for Rapid Neutralization Assessment
por: Jaron, Marcel, et al.
Publicado: (2022)

Production of CCHF virus-like particle by a baculovirus-insect cell expression system
por: Zhou, Zhao-rui, et al.
Publicado: (2011)

Tracking the virus-like particles of Macrobrachium rosenbergii nodavirus in insect cells
por: Hanapi, Ummi Fairuz, et al.
Publicado: (2017)

Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials
por: Hao, Chunyan, et al.
Publicado: (2017)

Zika virus-like particles (VLPs) produced in insect cells
por: de Mello, Renata Gois, et al.
Publicado: (2023)

Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
por: Wang, Chong, et al.
Publicado: (2016)

Effective Chikungunya Virus-like Particle Vaccine Produced in Insect Cells
por: Metz, Stefan W., et al.
Publicado: (2013)

Production of influenza virus-like particles using recombinant insect cells
por: Matsuda, Takuya, et al.
Publicado: (2020)

Construction of SARS-CoV-2 virus-like particles in plant
por: Moon, Ki-Beom, et al.
Publicado: (2022)

A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Protective Immune Responses in M. tuberculosis H37Ra Infected Mice
por: Wang, Juan, et al.
Publicado: (2023)

Correction: Wang et al. A VLP-Based Vaccine Displaying HBHA and MTP Antigens of Mycobacterium tuberculosis Induces Potentially Protective Immune Responses in M. tuberculosis H37Ra Infected Mice. Vaccines 2023, 11, 941
por: Wang, Juan, et al.
Publicado: (2023)

Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

Symbiont-mediated functions in insect hosts
por: Su, Qi, et al.
Publicado: (2013)

Minimal system for assembly of SARS-CoV-2 virus like particles
por: Swann, Heather, et al.
Publicado: (2020)

A perspective on SARS-CoV-2 virus-like particles vaccines
por: Gao, Xiaoyang, et al.
Publicado: (2023)

Expression and Immunogenicity of SARS-CoV-2 Virus-Like Particles based on Recombinant Truncated HEV-3 ORF2 Capsid Protein
por: Zhou, Yong-Fei, et al.
Publicado: (2022)

THE STRUCTURE OF INSECT VIRUS PARTICLES
por: Smith, Kenneth M.
Publicado: (1956)

SARS-CoV-2 virus-like-particles via liposomal reconstitution of spike glycoproteins
por: McColman, Sarah, et al.
Publicado: (2023)

Structural stability of SARS-CoV-2 virus like particles degrades with temperature
por: Sharma, A., et al.
Publicado: (2021)

Cetylpyridinium chloride promotes disaggregation of SARS-CoV-2 virus-like particles
por: Bañó-Polo, Manuel, et al.
Publicado: (2022)

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022)

Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles
por: Gourdelier, Manon, et al.
Publicado: (2022)

Microscopic observations of SARS‐CoV‐2 like particles in different oral samples
por: Brahim Belhaouari, Djamal, et al.
Publicado: (2022)

Multi-Stage Tuberculosis Subunit Vaccine Candidate LT69 Provides High Protection against Mycobacterium tuberculosis Infection in Mice
por: Niu, Hongxia, et al.
Publicado: (2015)

Corrigendum: IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation
por: Liu, Xun, et al.
Publicado: (2020)

IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation
por: Liu, Xun, et al.
Publicado: (2019)

Residual Baculovirus in Insect Cell-Derived Influenza Virus-Like Particle Preparations Enhances Immunogenicity
por: Margine, Irina, et al.
Publicado: (2012)

Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2021)

Author Correction: Minimal system for assembly of SARS-CoV-2 virus like particles
por: Swann, Heather, et al.
Publicado: (2021)

Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
por: Zak, Andrew J., et al.
Publicado: (2023)

A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice
por: Lu, Jing, et al.
Publicado: (2020)

Microscopic Observation of SARS-Like Particles in RT-qPCR SARS-CoV-2 Positive Sewage Samples
por: Brahim Belhaouari, Djamal, et al.
Publicado: (2021)

Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
por: Yang, Yongping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r2p99sr39putijf1jb0mghb3dv